{
 "@context": "https://schema.org",
 "@type": "Claim",
 "@id": "https://wulfkaal.github.io/positions/2026-07-31-5630",
 "identifier": "kaal:position:2026-07-31-5630",
 "additionalType": "https://wulfkaal.github.io/positions/schema.json#AffirmedPositionClaim",
 "name": "Historical 78D42849E185E94A36A9",
 "text": "The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders should be assessed against Kaal's source-bound claim that Asymmetric hedge fund regulation, in which Dodd-Frank and the AIFM Directive regulate banks and hedge funds separately and differently, is counterproductive. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.",
 "author": {
  "@type": "Person",
  "name": "Wulf A. Kaal",
  "identifier": "https://orcid.org/0009-0008-7840-1847"
 },
 "datePublished": "2026-07-31",
 "dateModified": "2026-07-31",
 "creativeWorkStatus": "Affirmed",
 "responseType": "qualification",
 "keywords": [
  "dynamic-regulation"
 ],
 "scope_conditions": [
  "US and EU hedge funds operate in the same markets with similar strategies",
  "External evidence level: abstract indexed.",
  "Mapping review tier: ambiguity triage before claim review.",
  "The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence."
 ],
 "currentDebate": {
  "name": "The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders",
  "url": "https://www.semanticscholar.org/paper/624afcfe682608a26a001d8abef6fa233712270b"
 },
 "extends": {
  "identifier": "kaal:claim:1806252-004",
  "url": "https://wulfkaal.github.io/claims/1806252-004",
  "citation": "Kaal, Hedge Fund Regulation Via Basel III (2011). SSRN: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1806252",
  "paper": "Hedge Fund Regulation Via Basel III",
  "authors": [
   "Wulf A. Kaal"
  ],
  "year": "2011",
  "ssrn": "",
  "source_pdf_sha256": "3343ebfe05a925c3d1a75625c4b351ccff515c50819a48d155804daacf01429d"
 },
 "isBasedOn": [
  {
   "@id": "https://wulfkaal.github.io/claims/1806252-004"
  },
  {
   "@type": "CreativeWork",
   "name": "The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders",
   "url": "https://www.semanticscholar.org/paper/624afcfe682608a26a001d8abef6fa233712270b"
  }
 ],
 "batch_id": "historical-backfill:2026-07-31:phase-0023",
 "review_provenance": "https://kaal-signal-desk.wulf577462.chatgpt.site/#review",
 "publicationStatus": "public",
 "recordTypeNote": "Dated commentary position extending a scholarly corpus claim. Not a verbatim claim extracted from the paper.",
 "isPartOf": {
  "@id": "https://wulfkaal.github.io/positions/index.json"
 },
 "version": "1.0",
 "canonical_url": "https://wulfkaal.github.io/positions/2026-07-31-5630",
 "canonicalForm": "https://wulfkaal.github.io/positions/2026-07-31-5630.md",
 "candidateId": "kaal:response-candidate:2026-07-31:e2debb0ba86bcc29",
 "evidenceLevel": "abstract indexed",
 "reviewTier": "ambiguity triage before claim review",
 "mappingConfidence": 0.2014,
 "mappingAmbiguous": true,
 "mappingMethod": "idf-weighted multi-field mapping v1",
 "mappingWhyRelevant": "Shared high-information concepts: dynamic, regulation, separately. Scope: US and EU hedge funds operate in the same markets with similar strategies.",
 "sourceProvenance": {
  "source": "Semantic Scholar",
  "api": "https://api.semanticscholar.org/graph/v1/paper/search/bulk",
  "query": "dynamic regulation",
  "queryId": "concept:516a267369f9",
  "page": 3,
  "sourceRank": 2983,
  "retrievedAt": "2026-07-31T13:58:15.259Z",
  "citationCount": 71,
  "venue": "IBRO Neuroscience Reports",
  "publicationTypes": [
   "Review",
   "JournalArticle"
  ]
 },
 "userAffirmation": "Approved as written by Wulf A. Kaal on 2026-07-31.",
 "sha256": "cfb94b441064e644fa3077870921230d93fdeb7d08388b76de7666d820d0802f"
}